New Hope Healthcare Nanjing Investment Center (Limited Partnership) signed an agreement to acquire 3.7% stake in Nanjing Weili Zhibo Biotechnology Co., Ltd. from KPC Pharmaceuticals, Inc. (SHSE:600422) for CNY 30 million on March 14, 2021. Post completion, KPC Pharmaceuticals, Inc. will hold 2.4845% stake of Nanjing Weili Zhibo Biotechnology Co., Ltd. The Board of Directors of KPC Pharmaceuticals, Inc. has approved the transaction.